Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Emboline, Inc. secures $20 million in growth capital from Trinity Capital Inc. to advance their interventional heart procedure technology and prepare for the commercial launch of the Emboliner system.
Amount Raised
$20 Million
Round Type
Funding Round
Investors
Description
Trinity Capital Inc. has announced a commitment of $20 million in growth capital to Emboline, Inc., a MedTech company focused on interventional heart procedures. This funding will support Emboline's efforts to commercialize their Emboliner system, enhancing patient safety. The company is advancing through clinical trials and regulatory approvals for their innovative technology
Related People
Funding Insights
Based on industry dataWatching Emboline Inc? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan